window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 1, 2026

  • News
  • About Us
Contact Us

cell and gene therapy

  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    NanoSyrinx appoints Thomas Farrell as CEO

    NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

    January 14, 2026
  • Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,European biotech,Partnerships & Funding

    eXmoor and UCL partner to accelerate academic cell and gene therapy programmes

    eXmoor Pharma has formed a strategic collaboration with University College [...]

    December 3, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    November 6, 2025
  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    BBG Advanced Therapies and CELLforCURE partner to provide transatlantic ATMP manufacturing solutions

    BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

    October 7, 2025
  • Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Vitalant launches national service hubs to expand patient access to cell and gene therapies

    Vitalant has launched a national hub-and-spoke model to expand patient [...]

    October 6, 2025
  • Cell & Gene Therapy,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    EG 427 reports strong initial results for DNA therapy in neurogenic bladder trial

    EG 427 has released encouraging first clinical data from its [...]

    October 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Movers & Shakers,Pharmaceuticals and therapeutics

    Chrysalis appoints Adam Bartley as chief operating officer

    Chrysalis, a provider of GMP cleanroom hosting and support services [...]

    September 23, 2025
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding

    Vitalant and UPMC expand partnership to advance cell and gene therapy initiatives

    Vitalant, a national blood and biotherapies provider, is expanding its [...]

    September 8, 2025
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,European biotech,Partnerships & Funding,Patient Centricity

    Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development

    Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

    August 19, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Evestia Clinical acquires ICRC-Weyer to expand full-service clinical research in Europe
    Categories: Biotech, CDMOs & Manufacturing, Clinical Development, Clinical Trials, Partnerships & Funding
  • Mental health systems strain as demand and funding shifts drive push for multimodal care
    Categories: Digital Health, Healthcare leadership, Medical devices, Mental health, Regulatory Affairs
  • Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer
    Categories: Clinical studies, Drug Development, Oncology, Precision medicine, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top